| Authors: |
Rae CL; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK., Nombela C; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Rodríguez PV; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Ye Z; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Hughes LE; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK., Jones PS; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Ham T; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Rittman T; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Coyle-Gilchrist I; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Regenthal R; 3 Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, 04107, Germany., Sahakian BJ; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 5 Department of Psychiatry, University of Cambridge, CB2 0SZ, Cambridge, UK., Barker RA; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Robbins TW; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 6 Department of Experimental Psychology, University of Cambridge, CB2 3EB, Cambridge, UK., Rowe JB; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK james.rowe@mrc-cbu.cam.ac.uk. |
